ACTL6A and lung carcinoma: Increased cisplatin resistance was also identified in lung cancer cell lines overexpressing actin-like 6A (ACTL6A), which is a component of several complexes implicated in chromatin remodeling, including the NuA4/TIP60 histone acetyltransferase [110].